Enterprise Value
1.538B
Cash
119.3M
Avg Qtr Burn
N/A
Short % of Float
16.38%
Insider Ownership
0.78%
Institutional Own.
-
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NexoBrid® Details Thermal burns | Approved Quarterly sales | |
MACI® (Matrix-Induced Autologous Chondrocyte Implantation) Details Symptomatic chondral or osteochondral defects of the knee | Approved Quarterly sales | |
NexoBrid Details Thermal burns | Phase 3 Update |